Trial intelligence / Profile preview

Nicotinell Patch for Prevention of Postoperative Nausea and Vomiting in Non-smokers

NCT00553709Phase 2Terminated

Start
Oct 2007
Primary completion
Aug 2009
Modality
Transdermal Patches, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Nicotine patch with Placebo patch (2 arms). Primary endpoint: Prevention of Postoperative Nausea and Vomiting at 48 hours. Started Oct 2007; status: terminated.

02

Drugs

nicotine patch
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT00553709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00553709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call